Healthcare ABL Receivables: How Lenders Review Medicare, Medicaid, and Third-Party Payor AR

If you run finance for a healthcare provider and you have started talking to asset-based lenders, you have probably learned that two things come up on every call: the anti-assignment rules on Medicare and Medicaid, and the double-lockbox cash structure that works around them. Those are real, and we have written about both the Medicare, Medicaid, and third-party payor mechanics and the double-lockbox and net-collectable-value structure in detail. But here is what experienced healthcare CFOs eventually figure out: those are solved problems. Every credible healthcare ABL lender knows how to perfect against government receivables and how to build the cash plumbing. The structure is not what decides your deal.

What decides your deal — your advance rate, your eligibility carve-outs, your reserves, and whether the lender even gets to a term sheet — is whether your revenue-cycle data lets the lender trust what your receivables will actually collect. Healthcare AR is billed at gross charges that bear little relationship to cash. Denials, recoupments, contractual allowances, and patient-pay leakage all sit between the invoice and the deposit. A lender underwriting that pool is not buying your charges; it is buying your collection performance, and it will only advance against what your own history proves you collect. This post is the borrower-side preparation playbook for the AR review itself: what the lender wants to see, why each item moves the number, and how to have it ready before the first data request.

At Don Clarke Enterprises we package and place ABL facilities for hospitals, physician groups, surgery centers, diagnostic labs, home health and hospice agencies, behavioral health providers, skilled nursing facilities, and specialty pharmacies. Donald Clarke founded Asset Based Lending Consultants in 1986, was inducted into the SFNet Hall of Fame in 2021, authored Asset Based Lending Disciplines — the first textbook on the discipline — and has trained more than 5,000 lending professionals at institutions including GE Capital, JP Morgan Chase, Lloyds, and Barclays. The points below are the ones that consistently separate a healthcare deal that closes on workable terms from one that stalls in diligence.

Payor Mix Is the First Thing the Lender Models

Before a healthcare ABL lender looks at a single invoice, it wants a payor-mix-segmented AR aging — your receivables broken out by payor class, not lumped into one pool. The reason is that each class collects at a different rate, on a different timeline, with a different risk profile, and the lender builds the borrowing base class by class. A provider that hands over a single undifferentiated aging is asking the lender to assume the worst across the whole pool.

The standard segmentation is:

• Medicare — predictable adjudication, government credit, but governed by anti-assignment rules and exposed to recoupment. Often the single largest class for hospitals and post-acute providers.
• Medicaid (and managed Medicaid) — slower and more variable than Medicare, state-by-state differences, also anti-assignment.
• Commercial / managed care — closer to traditional commercial AR, but with payor-specific contract rates and authorization complexity. Subject to single-payor concentration caps.
• Self-pay / patient responsibility — deductibles, copays, balances after insurance, and uninsured. The lowest collection rates in the pool and almost always excluded from the borrowing base entirely.
• Other — workers' compensation, auto/personal injury, and other liability claims, typically advanced at low rates with long aging cutoffs if accepted at all.

The lender treats government concentration differently from commercial concentration. Because the credit behind Medicare and Medicaid is the federal or state government rather than a commercial counterparty, lenders will accept far higher government concentration — caps in the 70–100% range are not unusual — while still capping any single commercial payor in the 15–30% range. The way these concentration limits stack and compound through the borrowing base is the same waterfall logic we walk through in our ineligible calculations and cross-aging guide; the healthcare twist is simply that a handful of payors dominate the pool, so the concentration math bites harder and earlier.

Billed vs. Unbilled AR: Know the Difference Before You Are Asked

Healthcare providers carry two very different categories of receivable, and lenders treat them very differently. Billed AR is a claim that has been submitted to the payor and is awaiting adjudication or payment. Unbilled AR — sometimes called DNFB, "discharged not final billed" — is revenue earned for services rendered but not yet submitted, usually because coding, documentation, or charge capture is incomplete.

Billed AR is financeable. Unbilled AR generally is not, or is advanced against at a steep discount, because the claim has not been validated by the payor and the amount is still an estimate. A large or growing DNFB balance is also a red flag to a lender: it signals revenue-cycle bottlenecks, coding backlogs, or documentation problems that will eventually show up as denials. When you bring your AR data to a lender, separate billed from unbilled cleanly and be ready to explain your average days-to-bill. A provider that bills within a few days of discharge looks materially stronger than one carrying weeks of DNFB, even if the gross AR number is identical.

Aging Buckets and the Eligibility Window

Commercial ABL typically cuts off receivables at 90 days past invoice. Healthcare ABL uses a longer window — commonly 120, 150, or even 180 days — because legitimate healthcare claims simply take longer to adjudicate and pay, especially across government and managed-care payors. That longer window is a feature, not generosity; it reflects the real collection cycle. But it cuts both ways: receivables that age past the window roll out of the borrowing base, and aging that drifts older over time tells the lender your collection performance is deteriorating.

Lenders read the aging trend as much as the snapshot. A clean, stable aging distribution supports a higher advance rate; an aging that is creeping rightward — more dollars sitting in the 120-plus buckets quarter over quarter — invites tighter eligibility and a larger reserve. The general eligibility logic mirrors what we cover in our eligible vs. ineligible receivables guide, with healthcare-specific cutoffs layered on top.

Contractual Allowances: The Gap Between Charges and Cash

This is the single biggest difference between healthcare AR and commercial AR. A hospital may bill $100,000 in gross charges for a procedure that the contracted reimbursement rate values at $30,000. The $70,000 difference is the contractual allowance — the negotiated discount between provider and payor. A lender that advanced against gross charges would be advancing against money that will never arrive. So healthcare borrowing bases are built off net collectable value, and the contractual allowance calculation is the first and largest haircut applied to gross AR.

What the lender needs from you is a contractual allowance schedule by major payor, supported by historical collection data — ideally a rolling twelve-month lookback showing, payor by payor, what fraction of billed charges actually converted to cash. The quality of this data directly drives your advance rate. A provider whose contractual allowance assumptions are well-documented and stable gets a tighter, more favorable net-collectable calculation. A provider that cannot support its allowance estimates forces the lender to assume conservatively, which means a lower borrowing base. Lenders update the contractual allowance assumption on a rolling basis as actual collections come in, so the cleaner your historical data, the less the lender has to pad.

Denials and Recoupments: Healthcare Dilution

In commercial ABL, dilution — the gap between what is billed and what is collected, net of contractual terms — typically runs 1–4% and reflects returns, allowances, and credit memos. In healthcare, dilution is structurally larger and comes from two sources that commercial lenders rarely see at scale:

• Denials. Claims rejected by the payor for coding errors, missing documentation, eligibility problems, lack of prior authorization, or medical-necessity disputes. Some are appealable and ultimately collected; many are not. A high denial rate signals revenue-cycle weakness and directly raises the lender's dilution reserve.
• Recoupments and takebacks. Money the payor already paid and later claws back — through retroactive audits, overpayment determinations, or offsets against future remittances. Government payors in particular can recoup against current payments, which means cash you have already swept can effectively be reversed. This is why recoupment exposure is one of the things healthcare ABL lenders watch most closely.

The lender will ask for a denial and takeback history — denial rates by payor and by reason code, appeal success rates, and a recoupment history showing the magnitude and frequency of clawbacks. This is not a formality. Your net dilution rate after contractual allowances is the number that sets your advance rate within the typical 65–85% healthcare range. A provider running 3–5% net dilution lands near the top of the range; a provider at 10% or more lands near the bottom and may face a dedicated denial reserve on top. Cleaning up denial workflows, documenting medical necessity proactively, and tracking appeals to resolution are among the few levers a provider directly controls that measurably improve availability — the same principle behind the advance-rate drivers we detail in our advance rates guide.

Cash Control and the Double-Lockbox Question

Because Medicare and Medicaid cannot be assigned and the government payor cannot be directed to remit into a lender-controlled account, healthcare ABL uses a double-lockbox structure: a government-collections account the provider exclusively controls, with a standing daily sweep into a lender-controlled collateral account. We cover the legal and operational mechanics of that structure — including why a traditional DACA on the government account would violate the anti-assignment rules — in the double-lockbox article.

From a preparation standpoint, what you need to understand is that this structure takes time to stand up. The depositary bank, the borrower, and the lender all execute the cash-management documents, and re-directing government payor remittances through enrollment and EFT changes can take 30–90 days to flow through. Providers who identify their depository relationships early and start the payor re-direction process in parallel with diligence compress that timeline materially. For how cash control interacts with your day-to-day liquidity once the facility is live, our piece on full vs. springing cash dominion applies, with the healthcare overlay that the government-account sweep is the operative mechanic rather than a conventional dominion sweep.

The Field Exam Will Test Your Revenue Cycle

Healthcare ABL field exams go deeper into the revenue cycle than a typical commercial exam. The exam team validates the existence and eligibility of receivables, but it also tests your contractual allowance methodology against actual collections, reconciles your reported borrowing base to your billing system, samples claims to confirm they were properly submitted and adjudicated, and examines your denial and recoupment history for patterns the summary data might hide. Our general field examination guide explains the mechanics; for healthcare, expect particular focus on whether your net-collectable assumptions hold up under sampling. Providers whose revenue-cycle systems can produce clean, reconcilable data sail through; those who cannot spend the exam — and the weeks after it — building data the lender should have seen up front.

Healthcare AR Lender-Review Readiness Checklist

Use this as a pre-submission readiness check. The closer you are to "ready" on every row, the faster you reach a term sheet and the better the terms — because every gap here is something the lender resolves by assuming conservatively.

Item	What the lender wants	Why it moves the number
Payor mix	AR aging segmented by Medicare, Medicaid/managed Medicaid, commercial, self-pay, other	Borrowing base is built class by class; an unsegmented pool gets worst-case assumptions
Billed vs. unbilled AR	Clean split of submitted claims vs. DNFB, plus average days-to-bill	Only billed AR is financeable; large DNFB signals revenue-cycle bottlenecks
Aging buckets	Aging by class with 120–180 day cutoffs and quarter-over-quarter trend	Receivables past the window roll out; a rightward-drifting aging tightens eligibility
Contractual allowances	Allowance schedule by major payor, supported by 12-month collection history	Largest haircut from gross to net collectable; weak support forces conservative estimates
Denials	Denial rates by payor and reason code, plus appeal success rates	Drives the dilution reserve and the advance rate within the 65–85% range
Recoupments / takebacks	History of clawbacks and offsets by payor, with magnitude and frequency	Already-collected cash can be reversed; high exposure invites a dedicated reserve
Government payor handling	Enrollment/EFT setup and remittance routing for Medicare/Medicaid	Determines feasibility and timeline of the double-lockbox cash structure
Double lockbox / cash control	Depository relationships identified; willingness to execute cash-management docs	Standing up the structure can take 30–90 days; early start compresses the close
Patient-pay exclusions	Self-pay clearly identified and segregated	Excluded from the base entirely; mixing it in distorts the collection picture
Concentration	Exposure by individual payor, government vs. commercial	Commercial single-payor caps (15–30%) bind well before government caps (70–100%)
Field exam support	Revenue-cycle data reconcilable from billing system to reported borrowing base	Exam tests allowance methodology and samples claims; clean data avoids adjustments
Reporting cadence	Ability to produce borrowing base certificates and aging on the agreed cycle	Reliable, timely reporting is the cheapest trust-building concession a borrower can offer

The borrowing base certificate is the recurring deliverable that operationalizes most of this once the facility closes; if you are unfamiliar with how one is built and read, our line-by-line BBC walkthrough is the place to start.

How This Compares to Factoring

Some healthcare providers — particularly smaller agencies, staffing-heavy practices, and newer entities — consider medical receivables factoring instead of an ABL revolver. Factoring can fund faster and underwrites more on the payor than on the provider's financials, but it is typically more expensive and operates as a sale of receivables rather than a loan against them. The structural trade-offs are the same ones we lay out in our AR financing vs. factoring comparison; the healthcare-specific point is that the same anti-assignment and net-collectable realities apply either way, so the quality of your revenue-cycle data matters just as much to a factor as to an ABL lender.

This Sector Rewards Lender Specialization

The list of lenders that will quote a healthcare deal is much longer than the list that genuinely understands one. Contractual allowance methodology, denial and recoupment reserving, government-account cash structures, and payor-concentration math require credit, audit, and operations teams that have done healthcare before. A generalist that quotes a healthcare facility often backs off late in diligence or lands on terms that do not produce usable availability. Matching a provider to a true healthcare-ABL desk is exactly the kind of fit problem we describe in our guide to choosing the right ABL lender, and healthcare is one of the sectors where the specialization gap is widest.

Why DCE

We package and place ABL facilities for healthcare providers across the spectrum and we know the specific lender desks that have real healthcare teams — which ones will accept high government concentration, where the dilution and recoupment reserves get negotiated, and how to structure the cash management so it actually closes. We help providers assemble the payor-mix-segmented aging, the contractual allowance support, and the denial and recoupment history that turn a slow, conservative review into a fast, well-priced one. Don Clarke has been advising on asset-based lending since 1986 and has trained the senior underwriters at most major healthcare ABL lenders on this exact discipline.